Total Payments
$665,161
2024 Payments
$12,674
Companies
15
Transactions
700
Payment Breakdown by Category
Other$406,118 (61.1%)
Consulting$153,157 (23.0%)
Travel$82,232 (12.4%)
Food & Beverage$13,478 (2.0%)
Research$10,177 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348,658 | 131 | 52.4% |
| Consulting Fee | $153,157 | 41 | 23.0% |
| Travel and Lodging | $82,232 | 299 | 12.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $57,460 | 14 | 8.6% |
| Food and Beverage | $13,478 | 211 | 2.0% |
| Unspecified | $10,177 | 4 | 1.5% |
Payments by Type
General
$654,984
696 transactions
Research
$10,177
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $315,722 | 342 | $0 (2024) |
| SERVIER PHARMACEUTICALS LLC | $155,548 | 165 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $54,936 | 54 | $0 (2023) |
| Shire North American Group Inc | $53,787 | 87 | $0 (2018) |
| Servier Affaires Medicales | $37,300 | 4 | $0 (2021) |
| Adaptive Biotechnologies Corporation | $21,902 | 16 | $0 (2022) |
| Spectrum Pharmaceuticals Inc. | $7,249 | 8 | $0 (2018) |
| Kite Pharma, Inc. | $6,571 | 9 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $6,261 | 4 | $0 (2017) |
| PFIZER INC. | $4,602 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,674 | 9 | SERVIER PHARMACEUTICALS LLC ($11,068) |
| 2023 | $21,231 | 29 | SERVIER PHARMACEUTICALS LLC ($14,355) |
| 2022 | $83,816 | 83 | SERVIER PHARMACEUTICALS LLC ($59,144) |
| 2021 | $60,627 | 59 | Amgen Inc. ($49,467) |
| 2020 | $118,944 | 67 | Amgen Inc. ($46,672) |
| 2019 | $177,372 | 212 | Amgen Inc. ($124,011) |
| 2018 | $101,575 | 118 | Amgen Inc. ($47,876) |
| 2017 | $88,923 | 123 | Shire North American Group Inc ($40,677) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $18.13 | General |
| 11/15/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $110.23 | General |
| 11/13/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $14.39 | General |
| 07/31/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Oncology | ||||||
| 01/25/2024 | BTG International, Inc. | VORAXAZE (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 01/13/2024 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $11,050.00 | General |
| 12/10/2023 | Jazz Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $147.01 | General |
| 12/10/2023 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $42.80 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 10/13/2023 | SERVIER PHARMACEUTICALS LLC | Asparlas (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Oncology | ||||||
| 09/06/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Travel and Lodging | Cash or cash equivalent | $255.41 | General |
| Category: Oncology | ||||||
| 09/06/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Travel and Lodging | Cash or cash equivalent | $191.94 | General |
| Category: Oncology | ||||||
| 09/06/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Food and Beverage | Cash or cash equivalent | $27.69 | General |
| Category: Oncology | ||||||
| 09/06/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: Oncology | ||||||
| 08/29/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,290.00 | General |
| Category: Oncology | ||||||
| 08/24/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Travel and Lodging | In-kind items and services | $284.50 | General |
| Category: Oncology | ||||||
| 08/24/2023 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug) | Food and Beverage | In-kind items and services | $135.32 | General |
| Category: Oncology | ||||||
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,290.00 | General |
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | Cash or cash equivalent | $248.30 | General |
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | Cash or cash equivalent | $185.16 | General |
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | Cash or cash equivalent | $37.93 | General |
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | Cash or cash equivalent | $31.27 | General |
| 07/11/2023 | SERVIER PHARMACEUTICALS LLC | — | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Randomized, Adaptive Study Comparing the Efficacy andSafety of Defibrotide vs Best Supportive Care in the Prevention ofHepatic Veno-Occlusive Disease in Adult and Pediatric PatientsUndergoing Hematopoietic Stem Cell Transplant | Jazz Pharmaceuticals Inc. | $8,827 | 3 |
| A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant | Jazz Pharmaceuticals Inc. | $1,350 | 1 |
About Dr. Dan Douer, M.D
Dr. Dan Douer, M.D is a Hematology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700825171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Douer, M.D has received a total of $665,161 in payments from pharmaceutical and medical device companies, with $12,674 received in 2024. These payments were reported across 700 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($348,658).
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology
- Location New York, NY
- Active Since 06/04/2006
- Last Updated 08/04/2011
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1700825171
Products in Payments
- Blincyto (Biological) $310,733
- ONCASPAR (Drug) $120,918
- ONCASPAR (Biological) $51,110
- ASPARLAS (Drug) $42,704
- Erwinaze (Drug) $33,227
- clonoSEQ (Device) $21,902
- Defitelio (Drug) $10,298
- DEFITELIO (Drug) $8,438
- Oncaspar (Drug) $7,206
- TRISENOX (Drug) $6,261
- Kyprolis (Biological) $4,064
- RYLAZE (Drug) $2,663
- Marqibo (Drug) $699.52
- VORAXAZE (Drug) $542.80
- VYXEOS (Drug) $141.76
- Tarceva (Drug) $66.96
- Kyprolis (Drug) $23.65
- ERWINAZE (Drug) $22.53
- Asparlas (Drug) $6.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in New York
Dr. Barry Coller, M.d, M.D
Hematology — Payments: $10.2M
Hematology $10.2M
Louis Aledort, Md, MD
Hematology — Payments: $377,491
Hematology $377,491
Michael Mauro, Md, MD
Hematology — Payments: $374,307
Hematology $374,307
Faith Davies, Md, MD
Hematology — Payments: $373,421
Hematology $373,421
Ann Jakubowski, Md, MD
Hematology — Payments: $92,726
Hematology $92,726
Maria Palomba, Md, MD
Hematology — Payments: $70,690
Hematology $70,690